| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 139 |
| 1 | INFLIXIMAB | 118 |
| 2 | USTEKINUMAB | 72 |
| 3 | VEDOLIZUMAB | 53 |
| 4 | AZATHIOPRINE | 47 |
| 5 | METHOTREXATE SODIUM | 40 |
| 6 | PREDNISONE | 40 |
| 7 | METHOTREXATE | 37 |
| 8 | UPADACITINIB | 22 |
| 9 | ADALIMUMAB-AATY | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 1 | 0.0067 |
| 1 | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES WITH FLAVOR PACK | 1 | 0.0048 |
| 2 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 1 | 0.0034 |
| 3 | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS | 1 | 0.0026 |
| 4 | BUTALBITAL AND ACETAMINOPHEN | 1 | 0.0016 |
| 5 | SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID | 1 | 0.0014 |
| 6 | AMPICILLIN AND SULBACTAM | 1 | 0.0011 |
| 7 | THIOGUANINE | 2 | 0.0009 |
| 8 | COLESEVELAM HYDROCHLORIDE | 1 | 0.0009 |
| 9 | INFLIXIMAB-AXXQ | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 123 |
| 1 | Interleukin-12 Antagonist [EPC] | 72 |
| 2 | Interleukin-23 Antagonist [EPC] | 72 |
| 3 | Corticosteroid [EPC] | 55 |
| 4 | Integrin Receptor Antagonist [EPC] | 53 |
| 5 | Purine Antimetabolite [EPC] | 47 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 37 |
| 7 | Janus Kinase Inhibitor [EPC] | 22 |
| 8 | Aminosalicylate [EPC] | 15 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-12 Antagonist [EPC] | 72 | 0.0007 |
| 1 | Interleukin-23 Antagonist [EPC] | 72 | 0.0007 |
| 2 | Integrin Receptor Antagonist [EPC] | 53 | 0.0006 |
| 3 | Purine Antimetabolite [EPC] | 47 | 0.0005 |
| 4 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 5 | Bile Acid Sequestrant [EPC] | 3 | 0.0002 |
| 6 | Barbiturate [EPC] | 2 | 0.0002 |
| 7 | Aminosalicylate [EPC] | 15 | 0.0001 |
| 8 | Janus Kinase Inhibitor [EPC] | 22 | 0.0001 |
| 9 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |